XML 56 R40.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Stock-Based Compensation and Employee Benefit Plan (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract] |
Schedule of Fair Value Assumptions of Options Awarded | The fair value of each stock option award is estimated on the date of grant using the Black-Scholes option-pricing model using the assumptions in the following table:
| Year Ended December 31,
| 2022 | 2023 | 2024
Expected term (years) | 6.1 | 1.4 - 6.1 | 6.1
Risk-free interest rate | 0.3% - 2.2% | 3.6% - 5.0% | 4.3% - 4.4%
Expected volatility | 48.6% - 58.4% | 51.3% - 54.4% | 51.8% - 52.7%
Expected dividend yield | — |  | — |  | — |
Schedule of Stock Option Activity | A summary of stock option and RSU activity under the Plans was as follows (in millions, except per share amounts):
|  |  | Outstanding Stock Options |  | Outstanding Restricted Stock Units
|  |  | Number of Shares | Weighted- Average Exercise Price |  | Number of Shares | Weighted- Average Grant Date Fair Value
Balances as of December 31, 2022 |  |  | 22 |  | $ | 23.41 |  |  | 34 |  | $ | 77.07 |
Granted |  |  | 1 |  | 115.15 |  |  | 12 |  | 122.84 |
Increase in shares available for grant |  |  | — |  | — |  |  | — |  | — |
Exercised/Vested |  |  | (16) |  | 5.37 |  |  | (14) |  | 93.25 |
Canceled |  |  | — |  | 98.60 |  |  | (2) |  | 120.36 |
Balances as of December 31, 2023 |  |  | 7 |  | 71.76 |  |  | 30 |  | 85.35 |
Granted |  |  | 1 |  | 168.18 |  |  | 13 |  | 153.36 |
Increase in shares available for grant |  |  | — |  | — |  |  | — |  | — |
Exercised/Vested |  |  | (3) |  | 41.55 |  |  | (11) |  | 119.00 |
Canceled |  |  | — |  | — |  |  | (2) |  | 143.07 |
Balances as of December 31, 2024 |  |  | 5 |  | $ | 93.53 |  |  | 30 |  | $ | 97.93 |
| Number of Shares | Weighted- Average Exercise Price | Weighted- Average Remaining Contractual Life (years) | Aggregate Intrinsic Value
Options outstanding as of December 31, 2023 | 7 |  | $ | 71.76 |  | 5.77 | $ | 500 |
Options exercisable as of December 31, 2023 | 6 |  | 60.89 |  | 5.11 | 448 |
Options outstanding as of December 31, 2024 | 5 |  | 93.53 |  | 5.43 | 260 |
Options exercisable as of December 31, 2024 | 4 |  | 80.55 |  | 4.69 | 253 |
Schedule of RSU Activity | A summary of stock option and RSU activity under the Plans was as follows (in millions, except per share amounts):
|  |  | Outstanding Stock Options |  | Outstanding Restricted Stock Units
|  |  | Number of Shares | Weighted- Average Exercise Price |  | Number of Shares | Weighted- Average Grant Date Fair Value
Balances as of December 31, 2022 |  |  | 22 |  | $ | 23.41 |  |  | 34 |  | $ | 77.07 |
Granted |  |  | 1 |  | 115.15 |  |  | 12 |  | 122.84 |
Increase in shares available for grant |  |  | — |  | — |  |  | — |  | — |
Exercised/Vested |  |  | (16) |  | 5.37 |  |  | (14) |  | 93.25 |
Canceled |  |  | — |  | 98.60 |  |  | (2) |  | 120.36 |
Balances as of December 31, 2023 |  |  | 7 |  | 71.76 |  |  | 30 |  | 85.35 |
Granted |  |  | 1 |  | 168.18 |  |  | 13 |  | 153.36 |
Increase in shares available for grant |  |  | — |  | — |  |  | — |  | — |
Exercised/Vested |  |  | (3) |  | 41.55 |  |  | (11) |  | 119.00 |
Canceled |  |  | — |  | — |  |  | (2) |  | 143.07 |
Balances as of December 31, 2024 |  |  | 5 |  | $ | 93.53 |  |  | 30 |  | $ | 97.93 |
| Number of Shares | Weighted- Average Exercise Price | Weighted- Average Remaining Contractual Life (years) | Aggregate Intrinsic Value
Options outstanding as of December 31, 2023 | 7 |  | $ | 71.76 |  | 5.77 | $ | 500 |
Options exercisable as of December 31, 2023 | 6 |  | 60.89 |  | 5.11 | 448 |
Options outstanding as of December 31, 2024 | 5 |  | 93.53 |  | 5.43 | 260 |
Options exercisable as of December 31, 2024 | 4 |  | 80.55 |  | 4.69 | 253 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration